QA: Chemours Co in us_medicinal_products/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001627223_2020_Chemours_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001627223, Chemours Co

  xvar xval
0 LiabilitiesNoncurrent 4,904,000,000
1 LiabilitiesCurrent 1,541,000,000
2 remainder_Liabilities 118,000,000
3 AssetsCurrent 2,777,000,000
4 AssetsNoncurrent 748,000,000
5 PropertyPlantAndEquipmentNet 3,559,000,000
6 Goodwill 0
7 remainder_Assets 174,000,000
8 GeneralAndAdministrativeExpense 5,011,000,000
9 ResearchAndDevelopmentExpense 80,000,000
10 remainder_Expenses 223,000,000
11 remainder_Revenues 5,526,000,000
12 remainder_NetIncome -264,000,000
13 remainder_ComprehensiveNetIncome 215,000,000
  yvar yval
0 Liabilities 6,563,000,000
1 Assets 7,258,000,000
2 Expenses 5,314,000,000
3 Revenues 5,526,000,000
4 StockholdersEquity 695,000,000
5 NetIncome -52,000,000
6 ComprehensiveNetIncome 55,500,000
7 BaseVar 12,570,000,000
8 EconomicCapitalRatio 0.0935

Edgar->Model Mapping

Feature Distribution

Change over Time